Navigation Links
ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer

Lung cancer, the header among all forms of cancer, is avenged now by the new proven effective ZD1839.

It has been shown that ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, has confirmed, durable responses and safety in patients with advanced non-small cell lung cancer (NSCLC) as monotherapy and in combination with standard chemotherapy agents after segmental scrutinization in two different studies.

Vincent Miller, MD, of Memorial Sloan-Kettering Cancer Center in New York and the principal investigator of the first study said, "It is hoped that our study will be a prelude to better outcomes for NSCLC patients in the near future." No novel toxicities were seen with ZD1839 treatment in combination with standard chemotherapy.

In a second study, which addressed intermittent dosing of ZD1839 in Japanese patients with advanced lung cancer, more than 20% of patients showed partial responses to ZD1839 between 1 and 11 months.

With such promising results, researchers are now working on whether this drug can be used for other forms of cancer as well.
'"/>




Page: 1

Related medicine news :

1. Study Proves That MMR Vaccine Is Not Connected To Autistic Babies
2. Pilot Study Proves Home Abortions ‘Safe’
3. Many Nonprescription Cough Medicines Proves Ineffective
4. Less Invasive By Pass Surgery Proves Economical In The Long Run
5. Epidural Mistakes Proves To Be Fatal Blunders
6. Combined Anti-Fever Drug Therapy Proves Unsafe for Childhood Fever
7. Drug Trial Proves Nightmare for British Indian Student
8. Naturopathic Care Proves Beneficial for TMD Pain
9. Medtronic Device Proves Effective in Parkinson’s Diseas
10. Large Community Spirometry Screening Proves Successful
11. Pregabalin Proves Durable Pain Relief Option for Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... August 15, 2019 , ... The ASCP Foundation has ... directly affected by the closure of Hahnemann University Hospital in Philadelphia, which is ... the ASCP Foundation will be making hardship grants of up to $2,500 per ...
(Date:8/14/2019)... Colo. (PRWEB) , ... August 14, 2019 , ... Inc. ... #2008 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s ... #41 among Colorado based companies and #153 in the Health sector. The list represents ...
(Date:8/14/2019)... ... August 13, 2019 , ... In a recent Trivedi Effect workshop, Master Dahryn ... belief systems. , “Doubt can obliterate your old beliefs,” said Master Dahryn. “Doubt helps ... to expand your understanding and your awareness. Trust that the Divine has put you ...
(Date:8/12/2019)... ... 2019 , ... Cryotherapy has recently been the target of negative press due ... cause of Brown’s injury was not due to cryotherapy, but due to a failure ... such as the Dallas Cowboys, the Washington Redskins, the Denver Broncos and many more, ...
(Date:8/9/2019)... LOS ANGELES (PRWEB) , ... August 09, 2019 , ... ... filed a class action complaint alleging that Mrs. Gooch's Natural Food Markets, Inc., ... California law. The Mrs. Gooch's Natural Food Markets, Inc., class action lawsuit, Case No. ...
Breaking Medicine News(10 mins):
(Date:8/14/2019)... PLAINS, N.J. (PRWEB) , ... August 14, 2019 ... ... in Lawrenceville, New Jersey has been reviewed and approved by NJ Top Docs ... care to treat his patients' urological ailments. , “Whether you require a ...
(Date:8/12/2019)... ... August 12, 2019 , ... Intalere, the healthcare industry leader in delivering ... finalist in the Innovator of The Year - Health IT category of the Pittsburgh ... by the Pittsburgh Technology Center as a healthcare IT innovator in the Pittsburgh area,” ...
(Date:8/10/2019)... ... August 10, 2019 , ... Thumb sucking is natural for infants ... 4 years of age, but past that the habit can contribute to dental problems. ... help parents know when to intervene and help their child stop the habit. , ...
Breaking Medicine Technology: